Alnylam Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
USD
328.73
24.73 (8.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
8.13%
0.11%
1W
8.22%
1.63%
1M
30.89%
-4.34%
YTD
39.7%
-3.84%
1Y
114.2%
16.08%
3Y
148.83%
60.19%
5Y
153.43%
63.75%
10Y
153.43%
217.58%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
41.04%
0%
41.04%
6 Months
29.47%
0%
29.47%
1 Year
114.2%
0%
114.2%
2 Years
72.26%
0%
72.26%
3 Years
148.83%
0%
148.83%
4 Years
101.35%
0%
101.35%
5 Years
153.43%
0%
153.43%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary